Highlighting Clinical Trial Results & Future Directions From the MiSLE Study in Lupus
2:00 pm - Wednesday 2nd December 2026
- Presenting key findings from the MiSLE trial, equipping attendees with the latest efficacy and safety insights for MSC therapies in lupus
- Comparing MSC approaches with CAR-T modalities, enabling clearer understanding of relative risks and benefits to guide platform selection
- Outlining lessons learned and next-step strategies following trial readouts, supporting future clinical development and regulatory planning
